India’s fintech revolution has matured into a trillion-dollar opportunity by 2030, reshaping how hundreds of millions manage, borrow, invest, and insure their finances.
India’s biotechnology industry, one of the fastest-expanding sectors globally, is blazing new trails across healthcare, pharmaceuticals, and sustainability.
Motilal Oswal Financial Services has reiterated its BUY call on Laurus Labs, highlighting a robust earnings trajectory and strategic capital deployment in CDMO and generics segments.
SoftBank Group has successfully raised $2.9 billion through a hybrid bond issuance that underscores founder Masayoshi Son’s bold, long-term vision for artificial intelligence.